Clinical Trial Update: High Dose Inhaled Mannitol Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating high-dose inhaled mannitol in bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Inhaled Mannitol (mannitol)

Snippet

Sponsor: Syntara | Conditions: Bronchiectasis | Phase 1, Phase 2 | Status: COMPLETED